Harmony Biosciences Holdings HRMY paid Brownstein Hyatt Farber Schreck $50K for lobbying in Q1 2026 · Health Issues

Trade details

Type: Lobbying report
Amount: $50,000
Quarter: Q1 2026
Stock: Harmony Biosciences Holdings HRMY
Client: Harmony Biosciences
Reported: 26/04/15

Up 0.0% from last quarter

What else happened in Harmony Biosciences Holdings around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Harmony Biosciences's other lobbying reports

Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$20K
$20K
Reported 07/20
for Q2
Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$50K
$50K
Reported 07/20
for Q2
Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$180K
$180K
Reported 07/20
for Q2
Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$50K
$50K
Reported 07/05
for Q2
Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$30K
$30K
Reported 05/04
for Q1

Harmony Biosciences Holdings HRMY paid Brownstein Hyatt Farber Schreck $50K for lobbying in Q1 2026 · Health Issues | Whalegun